From Mitochondrial Discovery to Approved Therapy: Lessons for the Future of Medicine
- Details
- Published on 15 April 2026
From Powerhouse to Prescription: Dr. Hazel Szeto Joins the WMS Annual Meeting 2026 as KEYNOTE Speaker. We are proud to announce that Hazel H. Szeto has accepted our invitation to join the WMS Annual Meeting – Targeting Mitochondria 2026, taking place in Berlin on October 21–23, 2026.
Dr. Szeto is internationally recognized for pioneering mitochondria-targeted therapeutics and for helping transform mitochondrial science into real medicine. Her work contributed to one of the first FDA-approved mitochondria-targeted therapies a historic milestone for the field.
She will deliver a keynote lecture:
From Mitochondrial Discovery to Approved Therapy: Lessons for the Future of Medicine
She will also join a high-level discussion with selected speakers:
How Do We Build the Next Successful Mitochondrial Drug?
Her participation reflects the direction of the field:
- From biology to therapeutics
- From discovery to translation
- From promise to patient benefit
The future of mitochondrial medicine will be discussed in Berlin.
Reed news on LinkedIn
Targeting Mitochondria 2026 Congress
October 21-23, 2026 - Berlin, Germany
www.targeting-mitochondria.com
